Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients

Background: Following myocardial infarction, mitral regurgitation (MR) is a common complication. Previous animal studies demonstrated the association of endothelial-to-mesenchymal transition (EndMT) with mitral valve (MV) remodeling. Nevertheless, little is known about how MV tissue responds to isch...

Full description

Bibliographic Details
Main Authors: Adrien Lupieri, Yasufumi Nagata, Livia S. A. Passos, Dakota Beker-Greene, Katherine A. Kirkwood, Jill Wylie-Sears, Zahra Alvandi, Hideyuki Higashi, Judy W. Hung, Sasha A. Singh, Joyce Bischoff, Robert A. Levine, Elena Aikawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.688396/full
id doaj-1cca0143f9ba4ac497b9433d0b2e35c8
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Adrien Lupieri
Yasufumi Nagata
Livia S. A. Passos
Dakota Beker-Greene
Katherine A. Kirkwood
Jill Wylie-Sears
Zahra Alvandi
Hideyuki Higashi
Judy W. Hung
Sasha A. Singh
Joyce Bischoff
Robert A. Levine
Elena Aikawa
Elena Aikawa
Elena Aikawa
spellingShingle Adrien Lupieri
Yasufumi Nagata
Livia S. A. Passos
Dakota Beker-Greene
Katherine A. Kirkwood
Jill Wylie-Sears
Zahra Alvandi
Hideyuki Higashi
Judy W. Hung
Sasha A. Singh
Joyce Bischoff
Robert A. Levine
Elena Aikawa
Elena Aikawa
Elena Aikawa
Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients
Frontiers in Cardiovascular Medicine
ischemic mitral regurgitation
mitral valve
endothelial-to-mesenchymal transition
proteomics
echocardiography
histo-cytometry
author_facet Adrien Lupieri
Yasufumi Nagata
Livia S. A. Passos
Dakota Beker-Greene
Katherine A. Kirkwood
Jill Wylie-Sears
Zahra Alvandi
Hideyuki Higashi
Judy W. Hung
Sasha A. Singh
Joyce Bischoff
Robert A. Levine
Elena Aikawa
Elena Aikawa
Elena Aikawa
author_sort Adrien Lupieri
title Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients
title_short Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients
title_full Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients
title_fullStr Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients
title_full_unstemmed Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human Patients
title_sort integration of functional imaging, cytometry, and unbiased proteomics reveals new features of endothelial-to-mesenchymal transition in ischemic mitral valve regurgitation in human patients
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2021-08-01
description Background: Following myocardial infarction, mitral regurgitation (MR) is a common complication. Previous animal studies demonstrated the association of endothelial-to-mesenchymal transition (EndMT) with mitral valve (MV) remodeling. Nevertheless, little is known about how MV tissue responds to ischemic heart changes in humans.Methods: MVs were obtained by the Cardiothoracic Surgical Trials Network from 17 patients with ischemic mitral regurgitation (IMR). Echo-doppler imaging assessed MV function at time of resection. Cryosections of MVs were analyzed using a multi-faceted histology and immunofluorescence examination of cell populations. MVs were further analyzed using unbiased label-free proteomics. Echo-Doppler imaging, histo-cytometry measures and proteomic analysis were then integrated.Results: MVs from patients with greater MR exhibited proteomic changes associated with proteolysis-, inflammatory- and oxidative stress-related processes compared to MVs with less MR. Cryosections of MVs from patients with IMR displayed activated valvular interstitial cells (aVICs) and double positive CD31+ αSMA+ cells, a hallmark of EndMT. Univariable and multivariable association with echocardiography measures revealed a positive correlation of MR severity with both cellular and geometric changes (e.g., aVICs, EndMT, leaflet thickness, leaflet tenting). Finally, proteomic changes associated with EndMT showed gene-ontology enrichment in vesicle-, inflammatory- and oxidative stress-related processes. This discovery approach indicated new candidate proteins associated with EndMT regulation in IMR.Conclusion: We describe an atypical cellular composition and distinctive proteome of human MVs from patients with IMR, which highlighted new candidate proteins implicated in EndMT-related processes, associated with maladaptive MV fibrotic remodeling.
topic ischemic mitral regurgitation
mitral valve
endothelial-to-mesenchymal transition
proteomics
echocardiography
histo-cytometry
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.688396/full
work_keys_str_mv AT adrienlupieri integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT yasufuminagata integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT liviasapassos integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT dakotabekergreene integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT katherineakirkwood integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT jillwyliesears integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT zahraalvandi integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT hideyukihigashi integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT judywhung integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT sashaasingh integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT joycebischoff integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT robertalevine integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT elenaaikawa integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT elenaaikawa integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
AT elenaaikawa integrationoffunctionalimagingcytometryandunbiasedproteomicsrevealsnewfeaturesofendothelialtomesenchymaltransitioninischemicmitralvalveregurgitationinhumanpatients
_version_ 1721209740748390400
spelling doaj-1cca0143f9ba4ac497b9433d0b2e35c82021-08-12T05:46:57ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2021-08-01810.3389/fcvm.2021.688396688396Integration of Functional Imaging, Cytometry, and Unbiased Proteomics Reveals New Features of Endothelial-to-Mesenchymal Transition in Ischemic Mitral Valve Regurgitation in Human PatientsAdrien Lupieri0Yasufumi Nagata1Livia S. A. Passos2Dakota Beker-Greene3Katherine A. Kirkwood4Jill Wylie-Sears5Zahra Alvandi6Hideyuki Higashi7Judy W. Hung8Sasha A. Singh9Joyce Bischoff10Robert A. Levine11Elena Aikawa12Elena Aikawa13Elena Aikawa14Division of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesCardiac Ultrasound Laboratory and Harvard Medical School, Massachusetts General Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDepartment of Population Health Science and Policy, Icahn School of Medicine, International Center for Health Outcomes and Innovation Research, New York, NY, United StatesVascular Biology Program and Department of Surgery, Boston Children's Hospital and Department of Surgery and Harvard Medical School, Boston, MA, United StatesVascular Biology Program and Department of Surgery, Boston Children's Hospital and Department of Surgery and Harvard Medical School, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesEchocardiography Laboratory, Division of Cardiology and Harvard Medical School, Massachusetts General Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesVascular Biology Program and Department of Surgery, Boston Children's Hospital and Department of Surgery and Harvard Medical School, Boston, MA, United StatesCardiac Ultrasound Laboratory and Harvard Medical School, Massachusetts General Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Excellence in Vascular Biology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDivision of Cardiovascular Medicine, Center for Interdisciplinary Cardiovascular Sciences and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, United StatesDepartment of Human Pathology, Sechenov First Moscow State Medical University, Moscow, RussiaBackground: Following myocardial infarction, mitral regurgitation (MR) is a common complication. Previous animal studies demonstrated the association of endothelial-to-mesenchymal transition (EndMT) with mitral valve (MV) remodeling. Nevertheless, little is known about how MV tissue responds to ischemic heart changes in humans.Methods: MVs were obtained by the Cardiothoracic Surgical Trials Network from 17 patients with ischemic mitral regurgitation (IMR). Echo-doppler imaging assessed MV function at time of resection. Cryosections of MVs were analyzed using a multi-faceted histology and immunofluorescence examination of cell populations. MVs were further analyzed using unbiased label-free proteomics. Echo-Doppler imaging, histo-cytometry measures and proteomic analysis were then integrated.Results: MVs from patients with greater MR exhibited proteomic changes associated with proteolysis-, inflammatory- and oxidative stress-related processes compared to MVs with less MR. Cryosections of MVs from patients with IMR displayed activated valvular interstitial cells (aVICs) and double positive CD31+ αSMA+ cells, a hallmark of EndMT. Univariable and multivariable association with echocardiography measures revealed a positive correlation of MR severity with both cellular and geometric changes (e.g., aVICs, EndMT, leaflet thickness, leaflet tenting). Finally, proteomic changes associated with EndMT showed gene-ontology enrichment in vesicle-, inflammatory- and oxidative stress-related processes. This discovery approach indicated new candidate proteins associated with EndMT regulation in IMR.Conclusion: We describe an atypical cellular composition and distinctive proteome of human MVs from patients with IMR, which highlighted new candidate proteins implicated in EndMT-related processes, associated with maladaptive MV fibrotic remodeling.https://www.frontiersin.org/articles/10.3389/fcvm.2021.688396/fullischemic mitral regurgitationmitral valveendothelial-to-mesenchymal transitionproteomicsechocardiographyhisto-cytometry